Adamis Pharmaceuticals Strengthens Patent Portfolio for Its Naloxone Product CandidateGlobeNewsWire • 02/17/21
Adamis Pharmaceuticals: Locking In Profits While Riding On The Back Of A PhoenixSeeking Alpha • 01/24/21
ADMP Stock: 4 Things to Know About Adamis Pharma Today as Shares Rocket AgainInvestorPlace • 01/22/21
SYMJEPI Products Now Available in the Walgreens Prescription Savings Club, with the Lowest Prices for Epinephrine ProductsGlobeNewsWire • 01/21/21
ADMP Stock Alert: The Covid-19 Treatment News That Has Adamis Pharma Shares Soaring TodayInvestorPlace • 01/20/21
Adamis Pharmaceuticals Announces IND Submission to FDA for Tempol for the Treatment of COVID-19GlobeNewsWire • 01/20/21
Adamis Pharmaceuticals Receives a Complete Response Letter from the FDA Regarding ZIMHIGlobeNewsWire • 11/16/20
Adamis Pharmaceuticals Corporation's (ADMP) CEO Dennis Carlo on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/10/20
Adamis Pharmaceuticals (ADMP) Reports Q3 Loss, Misses Revenue EstimatesZacks Investment Research • 11/09/20
Adamis Pharmaceuticals Announces Third Quarter 2020 Financial Results and Business UpdateGlobeNewsWire • 11/09/20
Adamis Pharmaceuticals Schedules Third Quarter 2020 Results Conference Call and Business UpdateGlobeNewsWire • 11/05/20
Will Adamis Pharmaceuticals (ADMP) Report Negative Q3 Earnings? What You Should KnowZacks Investment Research • 11/03/20
Adamis Pharmaceuticals Corporation (ADMP) CEO Dr. Dennis Carlo on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/21/20
Adamis Pharmaceuticals (ADMP) Reports Q2 Loss, Misses Revenue EstimatesZacks Investment Research • 08/17/20
Adamis Pharmaceuticals Announces Second Quarter 2020 Financial Results and Business UpdateGlobeNewsWire • 08/17/20